Zobrazeno 1 - 4
of 4
pro vyhledávání: '"Marit Holleman"'
Autor:
Puck T Pelzer, Marit Holleman, Michelle E H Helinski, Ana Lucia Weinberg, Joeri Buis, Pauline Beattie, Thomas Nyirenda, Job van Rest, Gerald Voss
Publikováno v:
PLoS ONE, Vol 19, Iss 10, p e0292981 (2024)
BackgroundThere are over ten vaccine candidates for tuberculosis (TB) in the clinical pipeline that require testing in TB-prevalent populations. To accelerate the clinical development of TB vaccines, a directory of clinical trial centres was establis
Externí odkaz:
https://doaj.org/article/c76eb4ed9b5347b3946b3df769640ba8
Autor:
Dominick Laddy, Gerald Voss, Dereck Tait, Ilona van den Brink, Marit Holleman, Maria Lempicki, Danielle Roordink, Leo van der Pol, Ann Williams, Anne Marie Graffin, Emmanuelle Gerdil, Jelle Thole, Bernard Fritzell, Georges Thiry
Publikováno v:
Tuberculosis (Edinburgh, Scotland)
Two proof of concept clinical trials with TB vaccines demonstrate that new approaches can prevent sustained TB infection in adolescents (BCG revaccination) and TB disease in adults (M72/ASO1E) (Nemes et al., 2018; Tait et al., 2019) [1,2]. Both appro
The 2012 Terrapinn World Vaccine Congress held from 16 to 18 October in Lyon addressed in a dedicated session the transfer of innovative vaccine technologies from Europe to emerging markets. Past and recent transfers and experiences from Europe’s p
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::de2993466c6ad5b3026d9b28dc9605a5
https://europepmc.org/articles/PMC3903917/
https://europepmc.org/articles/PMC3903917/
Publikováno v:
Vaccine. :A8-A11
Since 2008, the World Health Organization has provided seed grants to 11 manufacturers in low- and middle-income countries to establish or improve their pandemic influenza vaccine production capacity. To facilitate this ambitious project, an influenz